Matthew B. Purner

664 total citations
12 papers, 543 citations indexed

About

Matthew B. Purner is a scholar working on Epidemiology, Parasitology and Molecular Biology. According to data from OpenAlex, Matthew B. Purner has authored 12 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Parasitology and 5 papers in Molecular Biology. Recurrent topics in Matthew B. Purner's work include Toxoplasma gondii Research Studies (6 papers), Herpesvirus Infections and Treatments (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Matthew B. Purner is often cited by papers focused on Toxoplasma gondii Research Studies (6 papers), Herpesvirus Infections and Treatments (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Matthew B. Purner collaborates with scholars based in United States and France. Matthew B. Purner's co-authors include Tyler J. Curiel, Paul B. Nash, Ronald P. Leon, Richard C. Duke, Randolph L. Berens, E C Krug, James R. Berenson, Regina A. Swift, Robert Vescio and Hank H. Yang and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and The Journal of Infectious Diseases.

In The Last Decade

Matthew B. Purner

12 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew B. Purner United States 9 274 229 221 144 99 12 543
L. Cristina Gavrilescu United States 10 315 1.1× 120 0.5× 275 1.2× 19 0.1× 47 0.5× 14 551
Paula L. Hawthorne Australia 11 72 0.3× 237 1.0× 105 0.5× 52 0.4× 93 0.9× 13 663
Kenneth Munroe United States 7 109 0.4× 139 0.6× 84 0.4× 19 0.1× 34 0.3× 11 482
David G. Anders United States 19 243 0.9× 271 1.2× 986 4.5× 45 0.3× 308 3.1× 26 1.2k
Elvin J. Lauron United States 11 147 0.5× 149 0.7× 133 0.6× 13 0.1× 120 1.2× 15 570
Victor H. Van Cleave United States 10 223 0.8× 95 0.4× 247 1.1× 12 0.1× 51 0.5× 18 701
Lindsey B. Crawford United States 15 94 0.3× 144 0.6× 371 1.7× 20 0.1× 36 0.4× 31 592
Yona Zaffran United States 6 176 0.6× 70 0.3× 44 0.2× 73 0.5× 15 0.2× 8 402
Sabine Pingel Germany 13 80 0.3× 112 0.5× 378 1.7× 28 0.2× 76 0.8× 23 756
Kendra Speirs United States 8 183 0.7× 115 0.5× 135 0.6× 10 0.1× 83 0.8× 8 632

Countries citing papers authored by Matthew B. Purner

Since Specialization
Citations

This map shows the geographic impact of Matthew B. Purner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew B. Purner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew B. Purner more than expected).

Fields of papers citing papers by Matthew B. Purner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew B. Purner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew B. Purner. The network helps show where Matthew B. Purner may publish in the future.

Co-authorship network of co-authors of Matthew B. Purner

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew B. Purner. A scholar is included among the top collaborators of Matthew B. Purner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew B. Purner. Matthew B. Purner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Berenson, James R., Hank H. Yang, Robert Vescio, et al.. (2006). Phase I/II Trial Assessing Bortezomib and Melphalan Combination Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma. Journal of Clinical Oncology. 24(6). 937–944. 166 indexed citations
3.
4.
Connick, Elizabeth, Matthew B. Purner, Samantha MaWhinney, et al.. (2001). Relationship between Human Immunodeficiency Virus Type 1 (HIV‐1)–Specific Memory Cytotoxic T Lymphocytes and Virus Load after Recent HIV‐1 Seroconversion. The Journal of Infectious Diseases. 184(11). 1465–1469. 13 indexed citations
5.
Purner, Matthew B., Randolph L. Berens, Stanislas Tomavo, et al.. (1998). Stimulation of Human T Lymphocytes Obtained fromToxoplasma gondii‐Seronegative Persons by Proteins Derived fromT. gondii. The Journal of Infectious Diseases. 177(3). 746–753. 12 indexed citations
6.
Nash, Paul B., et al.. (1998). Toxoplasma gondii -Infected Cells Are Resistant to Multiple Inducers of Apoptosis. The Journal of Immunology. 160(4). 1824–1830. 179 indexed citations
7.
Purner, Matthew B., Randolph L. Berens, Paul B. Nash, et al.. (1996). CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans. Infection and Immunity. 64(10). 4330–4338. 41 indexed citations
8.
Purner, Matthew B., E C Krug, Peter Nash, et al.. (1995). Cross-Reactivity of Human Toxoplasma-Specific T Cells: Implications for Development of a Potential Immunotherapeutic or Vaccine. The Journal of Infectious Diseases. 171(4). 984–991. 8 indexed citations
9.
Maxwell, Ian H., L. Michael Glode, F Maxwell, et al.. (1994). Gene Therapy for B-cell Lymphoma in a SCID Mouse Model using an Immunoglobulin-Regulated Diphtheria Toxin Gene Delivered by a Novel Adenovirus-Polylysine Conjugate. PubMed. 9(2). 131–141. 14 indexed citations
10.
Purner, Matthew B., Randolph L. Berens, E C Krug, & Tyler J. Curiel. (1994). Epstein-Barr virus-transformed B cells, a potentially convenient source of autologous antigen-presenting cells for the propagation of certain human cytotoxic T lymphocytes. Clinical and Diagnostic Laboratory Immunology. 1(6). 696–700. 10 indexed citations
11.
Curiel, Tyler J., et al.. (1993). Cloned human CD4+ cytotoxic T lymphocytes specific for Toxoplasma gondii lyse tachyzoite-infected target cells.. The Journal of Immunology. 151(4). 2024–2031. 40 indexed citations
12.
Curiel, Tyler J., et al.. (1993). Cloned human CD4+ cytotoxic T lymphocytes specific for Toxoplasma gondii lyse tachyzoite-infected target cells. Parasitology Today. 9(11). 402–402. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Cristina Gavrilescu Breakdown of academic impact, for papers by Paula L. Hawthorne Breakdown of academic impact, for papers by Kenneth Munroe Breakdown of academic impact, for papers by David G. Anders Breakdown of academic impact, for papers by Elvin J. Lauron Breakdown of academic impact, for papers by Victor H. Van Cleave Breakdown of academic impact, for papers by Lindsey B. Crawford Breakdown of academic impact, for papers by Yona Zaffran Breakdown of academic impact, for papers by Sabine Pingel Breakdown of academic impact, for papers by Kendra Speirs
Rankless by CCL
2026